Danish cohort study identifies ten clinically distinct schizophrenia subgroups with genetic associations

This observational cohort study analyzed Danish nationwide registry data from the iPSYCH cohort, including 11,046 individuals with schizophrenia spectrum disorder (SSD) and 11,046 matched population controls. The research aimed to explore heterogeneity in SSD by integrating real-world clinical data with genetic variation. A subset of 5,969 individuals had exome data available for rare variant analysis.

The study identified ten clinically distinct SSD subgroups based on clinical characteristics. Analysis showed subgroup-specific enrichment of polygenic scores for five psychiatric disorders, though specific effect sizes and p-values were not reported. In the exome subset, researchers observed suggestive network-specific trends in rare deleterious variant burden across schizophrenia-informed gene sets and protein-protein interaction networks, but these findings were described as trends rather than definitive results.

No safety or tolerability data were reported as this was a genetic association study without intervention. Key limitations include the observational nature of the data, which precludes causal inference, and the fact that rare variant analysis was conducted on only a subset of the cohort (5,969 individuals). The genetic findings represent associations and trends that require replication and functional validation before having direct clinical application.